Handbook of Human Tissue Sources

Size: px
Start display at page:

Download "Handbook of Human Tissue Sources"

Transcription

1 ABBREVIATIONS ACTG ADA AFDIL AFIP AIDS ALL AMB AM-CTC AML ARC ARNC ART ASCO BBDR BTR CALGB CAP CBCTR CCCBB CCG CCOP CDC cdna AIDS Clinical Trials Group American Diabetes Association Armed Forces DNA Identification Laboratory Armed Forces Institute of Pathology Acquired Immune Deficiency Syndrome Acute lymphoblastic leukemia AIDS Malignancy Bank AIDS-Malignancy Clinical Trials Consortium Acute myelogenous leukemia Alzheimer s Research Center Army-Navy Serum Repository Assisted reproductive technology American Society of Clinical Oncology Benign Breast Disease Registry Breast Tissue Repository Cancer and Leukemia Group B College of American Pathologists Cooperative Breast Cancer Tissue Resource Chicago Community Cord Blood Bank Children s Cancer Group Community Clinical Oncology Program Centers for Disease Control and Prevention Complementary DNA (deoxyribonucleic acid) xxiii

2 xxiv Handbook of Human Tissue Sources CFRBCS CGOP CHR CHTN CJD CLIA CLSS CME CMV CNS CNSC CODIS CPP CRISP CTI DIEP DISC DNA DoD EBV ECOG EPA EST FASEB FBI FDA GIVF GME GOG GVHD Cooperative Family Registry for Breast Cancer Studies Cooperative Group Outreach Program Center for Health Research Cooperative Human Tissue Network Creutzfeldt-Jakob disease Clinical Laboratory Improvement Amendments Central Laboratory Services Section Continuing Medical Education Cytomegalovirus Central nervous system Central Nervous System Consortium Combined DNA Index System Collaborative Perinatal Project Computer Retrieval of Information on Scientific Projects Critical Technologies Institute Diabetes in Early Pregnancy Study Diet Intervention Study in Children Deoxyribonucleic acid Department of Defense Epstein-Barr virus Eastern Cooperative Oncology Group Environmental Protection Agency Expressed Sequence Tag Federation of American Societies for Experimental Biology Federal Bureau of Investigation Food and Drug Administration Genetics and IVF Institute Graduate medical education Gynecologic Oncology Group Graft versus host disease

3 Abbreviations xxv H&E HBDI HD HHANES HIV HIVNET HNPCC IRB IRS MACS MBC MGH MRFIT MSSM MTS NBAC NBSB NCHS NCI NEOB NHANES NHATS NHES NHL NHLBI NHMP NIA NIAID NICHD Hematoxylin and Eosin Human Biological Data Interchange Hodgkin s disease Hispanic Health and Nutrition Examination Surveys Human Immunodeficiency Virus HIV Network for Prevention Trials Hereditary Nonpolyposis Colorectal Cancer Institutional Review Board Intergroup Rhabdomyosarcoma Study Multicenter AIDS Cohort Study Maryland Brain Center Massachusetts General Hospital Multiple Risk Factor Intervention Trial Mount Sinai School of Medicine Mid-America Transplant Services National Bioethics Advisory Commission National Biomonitoring Specimen Bank National Center for Health Statistics National Cancer Institute New England Organ Bank National Health and Nutrition Examination Surveys National Human Adipose Tissue Survey National Health Examination Surveys Non-Hodgkin s lymphoma National Heart, Lung, and Blood Institute National Human Monitoring Program National Institute on Aging National Institute of Allergy and Infectious Disease National Institute of Child Health and Human Development

4 xxvi Handbook of Human Tissue Sources NIDDK NIGMS NIH NIMH NINDS NIST NNRSB NPF NPTB NSABP NWTSG NYBC OCT OSU PCBs PCI PCNA PCO PCOS POG PPH PPT PSA R&D RMMSC RTOG SCOR SEER SHSF National Institutes of Diabetes and Digestive and Kidney Diseases National Institute of General Medical Sciences National Institutes of Health National Institute of Mental Health National Institute of Neurological Diseases and Stroke National Institute of Standards and Technology National Neurological Research Specimen Bank National Psoriasis Foundation National Psoriasis Tissue Bank National Surgical Adjuvant Breast and Bowel Project National Wilms Tumor Study Group New York Blood Center Optimum cutting temperature Ohio State University Polychlorinated biphenyls Pittsburgh Cancer Center Proliferating cell nuclear antigen Pathology Coordinating Office Polycystic ovary syndrome Pediatrics Oncology Group Primary pulmonary hypertension Polyp prevention trial Prostate-specific antigen Research and development Rocky Mountain Multiple Sclerosis Center Radiation Therapy Oncology Group Specialized Centers of Research Surveillance, Epidemiology, and End Results Program Split hand/split foot

5 Abbreviations xxvii SPORE SWOG TPSR TRP UAREP UCCC UCSF UMCC UNOS UPMC VA VAMC WHI WIHS WITS Specialized Program of Research Excellence Southwest Oncology Group Tissue Procurement Shared Resource Translational Research Program Universities Associated for Research and Education in Pathology University of Colorado Cancer Center The University of California at San Francisco University of Michigan Cancer Center United Network for Organ Sharing University of Pittsburgh Medical Center Department of Veterans Affairs Veterans Affairs Medical Center Women s Health Initiative Women s Interagency HIV Study Women and Infants Transmission Study

236 Handbook of Human Tissue Sources

236 Handbook of Human Tissue Sources INDEX ABC. See America s Blood Centers Academic medical centers, 46 66 Acquired Immune Deficiency Syndrome (AIDS) related tissue samples. See Human immunodeficiency virus (HIV) related tissue samples ACTG.

More information

LARGE TISSUE BANKS, REPOSITORIES, AND CORE FACILITIES

LARGE TISSUE BANKS, REPOSITORIES, AND CORE FACILITIES Chapter Three LARGE TISSUE BANKS, REPOSITORIES, AND CORE FACILITIES Large tissue banks and repositories exist in almost every sector of the scientific and medical communities, including the military, the

More information

National Cancer Institute Clinical Trial Cooperative Groups

National Cancer Institute Clinical Trial Cooperative Groups National Cancer Institute Clinical Trial Cooperative Groups Perspectives from the National Surgical Adjuvant Breast and Bowel Project Joyce Mull, MPM Director, Regulatory Affairs NSABP Foundation, Inc.

More information

Cooperative Group /JCOG. Multi-modality therapy. Cooperative Group. adjuvant therapy. Chemoradiation % % 7.5% 7.2% 7.0% 2.5% 2.1% 19.

Cooperative Group /JCOG. Multi-modality therapy. Cooperative Group. adjuvant therapy. Chemoradiation % % 7.5% 7.2% 7.0% 2.5% 2.1% 19. 2. 1. 3. 4. Cooperative Group 5. /JCOG 1. Multi-modality therapy 2. 3. 4. Cooperative Group 5. adjuvant therapy Chemoradiation 2000 : 239608, 2.5% 2.1% 3.1% 3.2% 4.2% 4.3% 6.4% 6.8% 6.9% 20913 8.7% 8.3%

More information

NCCN National Comprehensive Cancer Network Directory Information

NCCN National Comprehensive Cancer Network Directory Information Please provide the information requested below. The information contained herein is for NCCN purposes only and will not be published without your express written consent below. Name: Last First Middle

More information

Children s Oncology Group: What We Learned In The Merger Process

Children s Oncology Group: What We Learned In The Merger Process : What We Learned In The Merger Process Gregory H. Reaman, MD Professor of Pediatrics The George Washington University School of Medicine and Health Sciences PEDIATRIC ONCOLOGY GROUP Children s Oncology

More information

RECENT TRENDS. The Impact of the NCI and NIBIB

RECENT TRENDS. The Impact of the NCI and NIBIB The Impact of the NCI and NIBIB James Deye, Ph.D. Program Director on Medical Physics RECENT TRENDS doubling of the NIH budget over last 5 years; appointment of new heads of NIH and NCI; creation of NIBIB;

More information

BD-STEP: Tackling Key Issues Across Cancer Research and Care

BD-STEP: Tackling Key Issues Across Cancer Research and Care BD-STEP: Tackling Key Issues Across Cancer Research and Care Michelle Berny-Lang, Ph.D. Program Director Center for Strategic Scientific Initiatives Office of the Director, National Cancer Institute BD-STEP

More information

Aging and Cancer in HIV

Aging and Cancer in HIV Aging and Cancer in HIV Ronald Mitsuyasu, MD Professor of Medicine Director, UCLA Center for Clinical AIDS Research and Education Group Chairman, AIDS Malignancy Consortium (AMC) Age distribution of HIV-infected

More information

The NIH SBIR/STTR Program & Universities

The NIH SBIR/STTR Program & Universities The NIH SBIR/STTR Program & Universities SBIR/STTR & Commercialization of University Innovations February 5, 2014 Matthew Portnoy, Ph.D. SBIR/STTR Program Coordinator, NIH 1 Topics Size of NIH/HHS program

More information

Fogarty Initiatives for Building Capacity in HIV/AIDS

Fogarty Initiatives for Building Capacity in HIV/AIDS Fogarty Initiatives for Building Capacity in HIV/AIDS April 13, 2010 Michael P. Johnson, M.D., M.P.H Deputy Director Fogarty International Center Global Health Transition in 21 st Century the unfinished

More information

Action to Cure Kidney Cancer Campaign to Fund Kidney Cancer Research

Action to Cure Kidney Cancer Campaign to Fund Kidney Cancer Research Action to Cure Kidney Cancer 2016 Campaign to Fund Kidney Cancer Research Kidney Cancer Facts 9 th most common cancer in the U.S. Until recently, 3 rd highest rate of increasing incidence of all cancers

More information

THE BURDEN OF CANCER IN NEBRASKA: RECENT INCIDENCE AND MORTALITY DATA

THE BURDEN OF CANCER IN NEBRASKA: RECENT INCIDENCE AND MORTALITY DATA THE BURDEN OF CANCER IN NEBRASKA: RECENT INCIDENCE AND MORTALITY DATA Presented by: Bryan Rettig, MS Nebraska Dept. of Health & Human Services Division of Public Health May 31, 2017 Nebraska Cancer Registry

More information

Murtha Cancer Center The DoD Cancer Center of Excellence

Murtha Cancer Center The DoD Cancer Center of Excellence Accelerating Progress against Cancer through Collaboration Center of Excellence Oversight Board September 10, 2013 Colonel Craig D. Shriver, MC, USA. FACS Director 1 Summary Murtha Cancer Center Overview

More information

Population-based Patterns of HIV-related Hodgkin Lymphoma in the Greater San Francisco Bay Area:

Population-based Patterns of HIV-related Hodgkin Lymphoma in the Greater San Francisco Bay Area: Population-based Patterns of HIV-related Hodgkin Lymphoma in the Greater San Francisco Bay Area: 1988-98 Sally Glaser, Ph.D. Christina Clarke, Ph.D. Northern California Cancer Center Margaret Gulley, M.D.

More information

Challenges in studying risk factors for childhood cancer

Challenges in studying risk factors for childhood cancer Challenges in studying risk factors for childhood cancer Julie A. Ross, Ph.D. Professor and Director, Division of Epidemiology & Clinical Research Department of Pediatrics, University of Minnesota & Masonic

More information

Epidemiology of SV40-Associated Tumors

Epidemiology of SV40-Associated Tumors Epidemiology of SV40-Associated Tumors Susan G. Fisher, Ph.D. Chief, Division of Epidemiology Community & Preventive Medicine University of Rochester Background Mass polio immunization program in U.S.

More information

Dr. Sause: Clinical, Research, and Administration. Vilija N. Avizonis, MD Radiation Oncologist; Intermountain Medical Center; Murray, Utah

Dr. Sause: Clinical, Research, and Administration. Vilija N. Avizonis, MD Radiation Oncologist; Intermountain Medical Center; Murray, Utah Dr. Sause: Clinical, Research, and Administration Vilija N. Avizonis, MD Radiation Oncologist; Intermountain Medical Center; Murray, Utah Objectives: Identify Dr. Sause's educational achievements Discuss

More information

Epidemiology in Texas 2006 Annual Report. Cancer

Epidemiology in Texas 2006 Annual Report. Cancer Epidemiology in Texas 2006 Annual Report Cancer Epidemiology in Texas 2006 Annual Report Page 94 Cancer Incidence and Mortality in Texas, 2000-2004 The Texas Department of State Health Services Texas Cancer

More information

Neuroscience International Funding Opportunities at NINDS & NIH

Neuroscience International Funding Opportunities at NINDS & NIH Neuroscience International Funding Opportunities at NINDS & NIH Yuan Liu, PhD Chief, Office of International Activities of Neurological Disorders & Stroke (NINDS) s of Health (NIH) U.S.A. July 20, 2007

More information

IOM-ASCO Workshop. Cooperative Group Chairs Report. March 21, Jan Buckner, MD. Mayo Clinic Rochester, MN

IOM-ASCO Workshop. Cooperative Group Chairs Report. March 21, Jan Buckner, MD. Mayo Clinic Rochester, MN IOM-ASCO Workshop March 21, 2011 Cooperative Group Chairs Report Jan Buckner, MD Mayo Clinic Rochester, MN Therapeutic Advances Cooperative Groups have been successfully collaborating to conduct high-quality

More information

2016 Oncology Institute Annual Report

2016 Oncology Institute Annual Report 2016 Oncology Institute Annual Report Message from the Cancer Committee: On behalf of the Cancer Committee of The Methodist Hospitals, we are pleased to present to you our 2016 Oncology Institute Annual

More information

Planning, Priority Setting, and Budget Development for NIH AIDS Research

Planning, Priority Setting, and Budget Development for NIH AIDS Research Planning, Priority Setting, and Budget Development for NIH AIDS Research Robert W. Eisinger, Ph.D. Office of AIDS Research s of Health Focus of Presentation Overview of OAR Priority Setting Process Budget

More information

Pharmacotherapy Handbook

Pharmacotherapy Handbook Pharmacotherapy Handbook Eighth Edition Barbara G. Wells, PharmD, HP, FCCP, BCPP Dean and Professor Executive Director, Research Institute of Pharmaceutical Sciences School of Pharmacy, The University

More information

Table E1. Standardized Mortality Ratios for Total and Specific Causes of Death Parameter Radiologists Psychiatrists No. of Deaths

Table E1. Standardized Mortality Ratios for Total and Specific Causes of Death Parameter Radiologists Psychiatrists No. of Deaths RSNA, 2016 10.1148/radiol.2016152472 Table E1. Standardized Mortality Ratios for Total and Specific Causes of Death Parameter Radiologists Psychiatrists No. of Deaths Observed/Expected No. of Deaths Observed/Expected

More information

Burden of Cancer in California

Burden of Cancer in California Burden of Cancer in California California Cancer Reporting and Epidemiologic Surveillance Institute for Population Health Improvement UC Davis Health August 22, 2018 Outline 1. Incidence and Mortality

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Acuna SA, Fernandes KA, Daly C, et al. Cancer mortality among recipients of solidorgan transplantation in Ontario, Canada. JAMA Oncol. Published online January 7, 2016. doi:10.1001/jamaoncol.2015.5137

More information

Advancing Therapeutic Development for Pain and Opioid Use Disorder through Public-Private Partnerships

Advancing Therapeutic Development for Pain and Opioid Use Disorder through Public-Private Partnerships The National Academies of SCIENCES ENGINEERING MEDICINE Advancing Therapeutic Development for Pain and Opioid Use Disorder through Public-Private Partnerships Leadership The NIH Pain Consortium Mission

More information

Colorectal Cancer Screening

Colorectal Cancer Screening Colorectal Cancer Screening December 5, 2017 Connecticut Cancer Partnership 14th Annual Meeting Xavier Llor, M.D., PhD. Associate Professor of Medicine Co-Director, Cancer Genetics and Prevention Program

More information

Session II: Academic Research in Breast Cancer: Challenges and Opportunities Robert L. Comis, MD ECOG-ACRIN Group Co-Chair

Session II: Academic Research in Breast Cancer: Challenges and Opportunities Robert L. Comis, MD ECOG-ACRIN Group Co-Chair Session II: Academic Research in Breast Cancer: Challenges and Opportunities Robert L. Comis, MD ECOG-ACRIN Group Co-Chair Symposium: Innovation in Breast Cancer 2014 Madrid, Spain February 21, 2014 Cancer

More information

Nation nal Cancer Institute. Prevalence Projections: The US Experience

Nation nal Cancer Institute. Prevalence Projections: The US Experience Nation nal Cancer Institute Prevalence Projections: The US Experience State of Art Methods for the Analysis of Population- Based Cancer Data January 22-23, 2014 Ispra, Italy U.S. DEPARTMENT OF HEALTH AND

More information

Cancer in Utah: An Overview of Cancer Incidence and Mortality from

Cancer in Utah: An Overview of Cancer Incidence and Mortality from Cancer in Utah: An Overview of Cancer Incidence and Mortality from 1973-2010 A publication of the Utah Cancer Registry January 2014 Prepared by: C. Janna Harrell, MS Senior Research Analyst Kimberly A.

More information

Thank You. Presented By. Title Sponsor. Venue Host

Thank You. Presented By. Title Sponsor. Venue Host Thank You Presented By Title Sponsor Venue Host NIDDK Research: Opportunities for Partnering Vladimir Knezevic, M.D. Senior Advisor for Commercial Evaluation, Technology Advancement Office, National Institute

More information

What the IOM Report Means for Basic and Clinical Research December 1, 2012

What the IOM Report Means for Basic and Clinical Research December 1, 2012 What the IOM Report Means for Basic and Clinical Research December 1, 2012 Story C. Landis, PhD Director, National Institute of Neurological Disorders and Stroke American Epilepsy Society Annual Meeting

More information

JPMPG Review of the Defense Health Board Recommendations Regarding Pandemic Influenza Preparedness and Response

JPMPG Review of the Defense Health Board Recommendations Regarding Pandemic Influenza Preparedness and Response JPMPG Review of the Defense Health Board Recommendations Regarding Pandemic Influenza Preparedness and Response Informational Brief Lt Col Philip L. Gould Chair 1 Recommendations The DHB recommendations

More information

Radiation Oncology Study Guide

Radiation Oncology Study Guide Radiation Oncology Study Guide For the Initial CertificationQualifying (Computer-Based) Examination General and Radiation Oncology This examination is designed to assess your understanding of the entire

More information

Cancer A Superficial Introduction

Cancer A Superficial Introduction Cancer A Superficial Introduction Gabor Fichtinger, Queen s University Cancer some definitions Medical term: malignant neoplasm Class of diseases in which a group of cells display: uncontrolled growth

More information

Health Consultation CHILDHOOD CANCER INCIDENCE UPDATE: A REVIEW AND ANALYSIS OF CANCER REGISTRY DATA, FOR

Health Consultation CHILDHOOD CANCER INCIDENCE UPDATE: A REVIEW AND ANALYSIS OF CANCER REGISTRY DATA, FOR Health Consultation CHILDHOOD CANCER INCIDENCE UPDATE: A REVIEW AND ANALYSIS OF CANCER REGISTRY DATA, 2001-2005 FOR TOWNSHIP OF TOMS RIVER, OCEAN COUNTY, NEW JERSEY AUGUST 20, 2008 U.S. DEPARTMENT OF HEALTH

More information

2 Diagnosis and Staging of Cancer 2.1 Pathophysiology of cancer 2.2 Classification and staging 2.3 Diagnostic measures for specific cancer types

2 Diagnosis and Staging of Cancer 2.1 Pathophysiology of cancer 2.2 Classification and staging 2.3 Diagnostic measures for specific cancer types Oncology Nursing Sub-Specialty Module Reference: Gobel B. M., Triest-Robertson S. & Vogel W.H. (Eds). (205). Advanced Oncology Nursing Certificate Review and Resources Manual. Pittsburgh: Oncology Nursing

More information

HEALTH SCREENING QUESTIONNAIRE CT Work-up. Donor ID EdgeCell #:

HEALTH SCREENING QUESTIONNAIRE CT Work-up. Donor ID EdgeCell #: HEALTH SCREENING QUESTIONNAIRE CT Work-up Héma-Québec Registre des Donneurs de Cellules Souches 4045 Côte-vertu, St-Laurent, QC, Canada, H4R 2W7 Tél : + 514-832-1031 Fax : + 514-832-0266 www.hema-quebec.qc.ca

More information

OPTN/SRTR 2015 Annual Data Report: Deceased Organ Donation

OPTN/SRTR 2015 Annual Data Report: Deceased Organ Donation OPTN/SRTR 2015 Annual Data Report: Deceased Organ Donation A. K. Israni 1,2,3, D. Zaun 1, C. Bolch 1, J.D. Rosendale 4,5, C. Schaffhausen 3, J. J. Snyder 1,2, and B. L. Kasiske 1,3 1 Scientific Registry

More information

PANEL DISCUSSION: SCREENING FOR LUNG CANCER. Anthony D Weaver MD

PANEL DISCUSSION: SCREENING FOR LUNG CANCER. Anthony D Weaver MD PANEL DISCUSSION: SCREENING FOR LUNG CANCER Anthony D Weaver MD Disclosures Anthony Weaver has no relationships to disclose. Thank God! A panel of experts! An Equal Opportunity University Objectives 1.

More information

Executive Summary. This report provides the findings of a ten-month study requested by the Maryland

Executive Summary. This report provides the findings of a ten-month study requested by the Maryland Executive Summary This report provides the findings of a ten-month study requested by the Maryland Department of Health and Mental Hygiene of a possible cancer cluster among fire fighters in Anne Arundel

More information

The American Society of Hematology (ASH) represents more than 17,000 clinicians and

The American Society of Hematology (ASH) represents more than 17,000 clinicians and American Society of Hematology Statement to the House Appropriations Subcommittee on Labor, HHS, Education, and Related Agencies FY 2020 Funding for NIH and CDC The American Society of Hematology (ASH)

More information

Research Announcements for the Week Ending March 21, 2014

Research Announcements for the Week Ending March 21, 2014 Research Announcements for the Week Ending March 21, 2014 Compiled by Julie C. Kong, MEd, RD, LN,CRA Director of Research Services, UIC School of Public Health 1. Aging 2. Cancer 3. Hepatitis C 4. International

More information

The Clinical Research E-News

The Clinical Research E-News Volume 2: ISSUE 6: March 24, 2010 The Clinical Research E-News SPECIAL ALERT: The annual JOG investigator Meeting will be held at 5pm on May 10, 2010 at the Loews Hotel. Now Open: AZ1071, A Phase II Study

More information

The NIH STTR Program

The NIH STTR Program The NIH STTR Program May 1, 2015 Matthew Portnoy, Ph.D. SBIR/STTR Program Coordinator, NIH 1 Topics Size of NIH/HHS program Set-asides & spending Research Institutions and Universities in STTR Discretionary

More information

micrornas!as! Biomarkers! Landscape!

micrornas!as! Biomarkers! Landscape! GENReports: Market & Tech Analysis micrornas!as! Biomarkers! Landscape! > Enal Razvi, Ph.D. Managing Director Select Biosciences, Inc. enal@selectbio.us! Topic Introduction and Scope! The,focus,of,this,GEN,Market,&,Tech,Analysis,Report,is,to,provide,

More information

The Role of Outcomes Registries in Blood and Marrow Transplantation Mary M Horowitz, MD, MS Cape Town, South Africa November 2014

The Role of Outcomes Registries in Blood and Marrow Transplantation Mary M Horowitz, MD, MS Cape Town, South Africa November 2014 The Role of Outcomes Registries in Blood and Marrow Transplantation Mary M Horowitz, MD, MS Cape Town, South Africa November 2014 Worldwide Network for Blood and Marrow Transplantation Transplants A Little

More information

Breast Cancer Additional Reports

Breast Cancer Additional Reports Stage Distribution In/Out Migration In/Out Migration by Insurance Status Insurance Status Distance Traveled Breast Cancer Additional Reports First Course Treatment Stage I Days to First Treatment: Cases

More information

FY 2008 Appropriations for R&D and Public Health Programs (in millions)

FY 2008 Appropriations for R&D and Public Health Programs (in millions) FY 2008 Appropriations for R&D and Public Health Programs (in millions) AGENCY PROGRAM FY 2008 Appropriations Status: http://thomas.loc.gov/home/approp/app08.html FY 2008 : http://www.whitehouse.gov/omb/budget/fy2007/

More information

The Clinical Research E-News

The Clinical Research E-News Volume 2: ISSUE 11: June 2, 2010 The Clinical Research E-News SPECIAL ALERT: The quarterly CRA Meeting will be held at 8:30am on June 16, 2010 at the Bluemle Science Building room 105. Now Open: SWOG0777,

More information

ANNUAL CANCER REGISTRY REPORT-2005

ANNUAL CANCER REGISTRY REPORT-2005 ANNUAL CANCER REGISTRY REPORT-25 CANCER STATISTICS Distribution of neoplasms Of a total of 3,115 new neoplasms diagnosed or treated at the Hospital from January 25 to December, 25, 1,473 were seen in males

More information

Updates In Cancer Screening: Navigating a Changing Landscape

Updates In Cancer Screening: Navigating a Changing Landscape Updates In Cancer Screening: Navigating a Changing Landscape Niharika Dixit, MD I have no conflict of interest. 1 Why Should You Care Trends in Cancer Incidence by Site United States. Siegal Et al: CA

More information

NDRI Private Donor Program: Accelerating Biomedical Research via Private Donation

NDRI Private Donor Program: Accelerating Biomedical Research via Private Donation 1 NDRI Private Donor Program: Accelerating Biomedical Research via Private Donation Jeffrey Thomas Vice President, Strategic Initiatives Honesto Nunez III Private Donor/Rare Disease Manager Webinar Objectives

More information

Top Medical Meetings Calendar October 2016 September 2017

Top Medical Meetings Calendar October 2016 September 2017 - 2016- OCTOBER 7-11 European Cancer Congress and European Society for Medical Oncology 2016 Congress (ECCO/ESMO) Copenhagen 13-15 Lymphoma and Myeloma 2016 New York 14-19 American College of Gastroenterology

More information

Viral Hepatitis in the U.S.: Federal Partner Update

Viral Hepatitis in the U.S.: Federal Partner Update Viral Hepatitis in the U.S.: Federal Partner Update Corinna Dan, RN, M.P.H. Office of HIV/AIDS and Infectious Disease Policy October 20, 2015 1 Institute of Medicine Report, 2010 Hepatitis and Liver Cancer:

More information

Radiation Oncology MOC Study Guide

Radiation Oncology MOC Study Guide Radiation Oncology MOC Study Guide The following study guide is intended to give a general overview of the type of material that will be covered on the Radiation Oncology Maintenance of Certification (MOC)

More information

HEALTH SCREENING QUESTIONNAIRE. Work-up. Donor ID EdgeCell #:

HEALTH SCREENING QUESTIONNAIRE. Work-up. Donor ID EdgeCell #: HEALTH SCREENING QUESTIONNAIRE Héma-Québec Registre des Donneurs de Cellules Souches 4045 Côte-vertu, St-Laurent, QC, Canada, H4R 2W7 Tél : + 514-832-1031 Fax : + 514-832-0266 www.hema-quebec.qc.ca CT

More information

Overview PAUL J. PETRUSKA, M.D.

Overview PAUL J. PETRUSKA, M.D. Overview The Division of Hematology and Oncology continues to provide excellence in education, patient care, and clinical research. The division is currently staffed with six attending physicians, a certified

More information

Τhe unique constellation of tumors in AYA: Not an adult, not a child

Τhe unique constellation of tumors in AYA: Not an adult, not a child Τhe unique constellation of tumors in AYA: Not an adult, not a child Giannis Mountzios MSc, PhD Medical Oncologist 251 General Aiforce Hospital 2 nd Oncology Department, Henry Dunant Hospital Centre Athens,

More information

FACULTY MEMBERSHIP APPLICATION Tulane Cancer Center

FACULTY MEMBERSHIP APPLICATION Tulane Cancer Center FACULTY MEMBERSHIP APPLICATION Tulane Cancer Center 1430 Tulane Ave., Box SL-68, New Orleans, LA 70112-2699 J. Bennett Johnston Building, Mezzanine (Floor 1A), Suite A102 (504) 988-6060, fax (504) 988-6077,

More information

Leukine. Leukine (sargramostim) Description

Leukine. Leukine (sargramostim) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.10.08 Subject: Leukine Page: 1 of 6 Last Review Date: March 13, 2014 Leukine Description Leukine (sargramostim)

More information

Measure Description. Denominator Statement

Measure Description. Denominator Statement CMS ID/CMS QCDR ID: CAP 18 Title: Mismatch Repair (MMR) or Microsatellite Instability (MSI) Biomarker Testing to Inform Clinical Management and Treatment Decisions in Patients with Primary or Metastatic

More information

November 13, 2009 Licensure, Evaluation, and Adverse Event Monitoring of the 2009 H1N1 Influenza Vaccine By Matthew Watson and Jennifer Nuzzo

November 13, 2009 Licensure, Evaluation, and Adverse Event Monitoring of the 2009 H1N1 Influenza Vaccine By Matthew Watson and Jennifer Nuzzo www.upmc-biosecurity.org www.upmc-cbn.org November 13, 2009 Licensure, Evaluation, and Adverse Event Monitoring of the 2009 H1N1 Influenza Vaccine By Matthew Watson and Jennifer Nuzzo In response to the

More information

September 20, Submitted electronically to: Cc: To Whom It May Concern:

September 20, Submitted electronically to: Cc: To Whom It May Concern: History Study (NOT-HL-12-147), p. 1 September 20, 2012 Re: Request for Information (RFI): Building a National Resource to Study Myelodysplastic Syndromes (MDS) The MDS Cohort Natural History Study (NOT-HL-12-147).

More information

Survival in Teenagers and Young. Adults with Cancer in the UK

Survival in Teenagers and Young. Adults with Cancer in the UK Survival in Teenagers and Young Adults with Cancer in the UK Survival in Teenagers and Young Adults (TYA) with Cancer in the UK A comparative report comparing TYA cancer survival with that of children

More information

Cancer Statistics, 2009 Ahmedin Jemal, Rebecca Siegel, Elizabeth Ward, Yongping Hao, Jiaquan Xu and Michael J. Thun. DOI: /caac.

Cancer Statistics, 2009 Ahmedin Jemal, Rebecca Siegel, Elizabeth Ward, Yongping Hao, Jiaquan Xu and Michael J. Thun. DOI: /caac. Cancer Statistics, 2009 Ahmedin Jemal, Rebecca Siegel, Elizabeth Ward, Yongping Hao, Jiaquan Xu and Michael J. Thun CA Cancer J Clin 2009;59;225-249; originally published online May 27, 2009; DOI: 10.3322/caac.20006

More information

Ranking Minority Member Senate Committee on Armed Services Senate Committee on Armed Services Washington, DC Washington, DC 20510

Ranking Minority Member Senate Committee on Armed Services Senate Committee on Armed Services Washington, DC Washington, DC 20510 The Honorable John McCain The Honorable Jack Reed United States Senator United States Senator Chair Ranking Minority Member Senate Committee on Armed Services Senate Committee on Armed Services Washington,

More information

The Clinical Research E-News

The Clinical Research E-News Volume 3: ISSUE 3: February 16, 2011 The Clinical Research E-News Now Open: RTOG 0631, Phase II/III Study of Image-Guided Radiosurgery/SBRT for Localized Spine Metastasis RTOG 1010, A Phase III Trial Evaluating

More information

STANFORD CANCER CENTER. Clinical Studies. A Cancer Center Designated By The National Cancer Institute

STANFORD CANCER CENTER. Clinical Studies. A Cancer Center Designated By The National Cancer Institute STANFORD CANCER CENTER Clinical Studies A Cancer Center Designated By The National Cancer Institute Clinical Studies at Stanford AN IMPORTANT ASPECT OF THE ADVANCED CARE THAT STANFORD OFFERS IS THE OPPORTUNITY

More information

Key Words. Cancer statistics Incidence Lifetime risk Multiple primaries Survival SEER

Key Words. Cancer statistics Incidence Lifetime risk Multiple primaries Survival SEER The Oncologist Epidemiology and Population Studies: SEER Series Cancer Statistics, Trends, and Multiple Primary Cancer Analyses from the Surveillance, Epidemiology, and End Results (SEER) Program MATTHEW

More information

CITY OF BEVERLY HILLS. Office of Emergency Management MEMORANDUM

CITY OF BEVERLY HILLS. Office of Emergency Management MEMORANDUM CITY OF BEVERLY HILLS Office of Emergency Management MEMORANDUM TO: FROM: Health and Safety Commission Pamela Mottice Muller, Director DATE: July 25, 2016 SUBJECT: Health and Safety Observances Commemorative

More information

Overview of the NIH. National Institutes of Health (NIH)

Overview of the NIH. National Institutes of Health (NIH) Overview of the National Institutes of Health (NIH) October 16, 2008 Craig Formby, Ph.D. Distinguished Graduate Research Professor Colleges of Arts & Sciences, Medicine, and Engineering Director, Office

More information

Kaiser Permanente s Experience in Coverage and Conduct of Oncology Clinical Trials

Kaiser Permanente s Experience in Coverage and Conduct of Oncology Clinical Trials Kaiser Permanente s Experience in Coverage and Conduct of Oncology Clinical Trials IOM/ASCO Implementation Planning Workshop Sharon Levine MD Associate Executive Director, Kaiser Permanente March 21, 2011

More information

DISPARITIES IN PEDIATRIC CANCER CARE

DISPARITIES IN PEDIATRIC CANCER CARE Disclosure DISPARITIES IN PEDIATRIC CANCER CARE Anne Marie Langevin MD has no relationships with commercial companies to disclose. Anne-Marie Langevin, MD Hematologist/Oncologist Professor of Pediatrics

More information

The Clinical Research E-News

The Clinical Research E-News ISSUE 18: September 9, 2009 New Activations: The Clinical Research E-News SWOG0518, Phase III Prospective Randomized Comparison of Depot Octreotide Plus Interferon Alpha Versus Depot Octreotide Plus Bevacizumab

More information

Common Questions about Cancer

Common Questions about Cancer 6 What is cancer? Cancer is a group of diseases characterized by uncontrolled growth and spread of abnormal cells. The cancer cells form tumors that destroy normal tissue. If cancer cells break away from

More information

Cancer Statistics, 2011

Cancer Statistics, 2011 Cancer Statistics, 2011 Cancer Statistics, 2011 The Impact of Eliminating Socioeconomic and Racial Disparities on Premature Cancer Deaths Rebecca Siegel, MPH 1 ; Elizabeth Ward, PhD 2 ; Otis Brawley, MD

More information

OFFICE OF THE UNDER SECRETARY OF DEFENSE 4000 DEFENSE PENTAGON WASHINGTON, DC

OFFICE OF THE UNDER SECRETARY OF DEFENSE 4000 DEFENSE PENTAGON WASHINGTON, DC OFFICE OF THE UNDER SECRETARY OF DEFENSE 4000 DEFENSE PENTAGON WASHINGTON, DC 20301-4000 PERSONNEL AND READINESS The Honorable Adam Smith APR - 5 2019 Chairman Committee on Armed Services U.S. House of

More information

President's FY 2009 Budget Request for R&D and Public Health Programs

President's FY 2009 Budget Request for R&D and Public Health Programs Request for R&D and Public Health Programs (in millions) : http://www.whitehouse.gov/omb/budget/fy2007/ FY Final Appropriations: http://thomas.loc.gov/home/approp/app08.html FY Levels based on Documents

More information

The Clinical Research E-News

The Clinical Research E-News The Clinical Research E-News Volume 2: ISSUE 19: October 13, 2010 Coming soon: RTOG 0929, A Randomized, Phase I/II Study of ABT-888 in Combination with Temozolomide in Recurrent (Temozolomide Resistant)

More information

Leukine. Leukine (sargramostim) Description

Leukine. Leukine (sargramostim) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Leukine Page: 1 of 6 Last Review Date: November 30, 2018 Leukine Description Leukine (sargramostim)

More information

REPORT TO CONGRESS Multi-Disciplinary Brain Research and Data Sharing Efforts September 2013 The estimated cost of report or study for the Department of Defense is approximately $2,540 for the 2013 Fiscal

More information

Chapter 15: Non-Head and Neck Solid Tumors in Patients with Fanconi Anemia

Chapter 15: Non-Head and Neck Solid Tumors in Patients with Fanconi Anemia Chapter 15: Non-Head and Neck Solid Tumors in Patients with Fanconi Anemia Introduction Cancer is a major concern in FA patients. This chapter will describe the most common types of non-head and neck solid

More information

Cancer in New Mexico 2017

Cancer in New Mexico 2017 Cancer in New Mexico 0 Please contact us! Phone: 0-- E-Mail: nmtr-info@salud.unm.edu URL: nmtrweb.unm.edu TABLE OF CONTENTS Introduction... New Cases of Cancer Estimated Number of New Cancer Cases Description

More information

Long-term PHARMacovigilance for Adverse effects in Childhood arthritis focusing on Immune modulatory drugs

Long-term PHARMacovigilance for Adverse effects in Childhood arthritis focusing on Immune modulatory drugs Long-term PHARMacovigilance for Adverse effects in Childhood arthritis focusing on Immune modulatory drugs EMEA meeting, december 4, 2009 A European collaboration between pediatric rheumatology centers

More information

Washington, DC Washington, DC Washington, DC Washington, DC 20510

Washington, DC Washington, DC Washington, DC Washington, DC 20510 March 12, 2018 The Honorable Thad Cochran The Honorable Patrick Leahy Chairman Vice Chairman Committee on Appropriations Committee on Appropriations Washington, DC 20510 Washington, DC 20510 The Honorable

More information

Chapter III: Summary of Data for Specific Cancers

Chapter III: Summary of Data for Specific Cancers Chapter III: Summary of Data for Specific Cancers [This page left intentionally blank.] Chapter III Chapter III: Summary of Data for Specific Cancers This chapter provides detailed information on the most

More information

*

* Introduction Cancer is complex, can have many possible causes, and is increasingly common. For the U.S. population, 1 in 2 males and 1 in 3 females is at risk of developing cancer in their lifetime. The

More information

What are stem cells? A stem cell can differentiate into any one of 220 different specialised cells in the body STEM CELLS

What are stem cells? A stem cell can differentiate into any one of 220 different specialised cells in the body STEM CELLS What are stem cells? Stem cells are often called MASTER CELLS, and form the foundation for your entire body as building blocks for the blood, immune system, tissue and organs. They can REPLICATE or REGENERATE

More information

San Francisco, CA U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

San Francisco, CA U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland AWARD NUMBER: W81XWH-13-1-0054 TITLE: The Parkinson s Registry Investigation of Diagnosis and Etiology (PRIDE) Study PRINCIPAL INVESTIGATOR: Caroline M. Tanner, MD, PhD CONTRACTING ORGANIZATION: Northern

More information

Surgical oncology in Africa (Nigeria)

Surgical oncology in Africa (Nigeria) Surgical oncology in Africa (Nigeria) T. Peter Kingham MD, FACS Hepatobiliary Surgery Director of Global Cancer Disparity Initiatives Assoc. Attending Memorial Sloan Kettering Cancer Center Isaac Alatise,

More information

Top Medical Meetings Calendar March 2016 February 2017

Top Medical Meetings Calendar March 2016 February 2017 - 2016- MARCH 4-7 American Academy of Allergy, Asthma & Immunology 2016 Annual Meeting (AAAAI) Los Angeles 4-8 American Academy of Dermatology 74rd Annual Meeting (AAD) Washington DC 8-12 American College

More information

Barbara G. Wells, PharmD, FASHP, FCCP, BCPP Dean and Professor School of Pharmacy, The University of Mississippi Oxford, Mississippi

Barbara G. Wells, PharmD, FASHP, FCCP, BCPP Dean and Professor School of Pharmacy, The University of Mississippi Oxford, Mississippi Barbara G. Wells, PharmD, FASHP, FCCP, BCPP Dean and Professor School of Pharmacy, The University of Mississippi Oxford, Mississippi Joseph T. DiPiro, PharmD, FCCP Panoz Professor of Pharmacy, College

More information

INSTITUTO DE SALUD CARLOS III (ISCIII)

INSTITUTO DE SALUD CARLOS III (ISCIII) Instituto de Salud Carlos III 1 INSTITUTO DE SALUD CARLOS III (ISCIII) Institute of Health Carlos III ISCIII is a scientific support organisation to the National Health System, a public research centre

More information

Appendix Promoting Excellence in End-of-Life Care Demonstration Projects

Appendix Promoting Excellence in End-of-Life Care Demonstration Projects Baystate Medical Center, Springfield, MA Appendix Promoting Excellence in End-of-Life Care Demonstration Projects Grantee Site Project Name Project Description* Status Articles Describing Project Renal

More information

Cancer 101 Spring Family Cancer Retreat 4/18/15. Amish Shah, M.D. New Mexico Cancer Center

Cancer 101 Spring Family Cancer Retreat 4/18/15. Amish Shah, M.D. New Mexico Cancer Center Cancer 101 Spring Family Cancer Retreat 4/18/15 Amish Shah, M.D. New Mexico Cancer Center Topics to cover What is Cancer? Screening Diagnosis/Staging Treatment Basics Clinical Trials Surveillance What

More information

Marc Moss, MD President, American Thoracic Society (202) th St, N.W. #300 Washington, DC 20036

Marc Moss, MD President, American Thoracic Society (202) th St, N.W. #300 Washington, DC 20036 Marc Moss, MD President, American Thoracic Society Nmoore@thoracic.org; (202) 296. 9770 1150 18 th St, N.W. #300 Washington, DC 20036 STATEMENT OF THE AMERICAN THORACIC SOCIETY SUBMITTED TO THE HOUSE LABOR,

More information

GREATER BALTIMORE MEDICAL CENTER SANDRA & MALCOLM BERMAN CANCER INSTITUTE

GREATER BALTIMORE MEDICAL CENTER SANDRA & MALCOLM BERMAN CANCER INSTITUTE GREATER BALTIMORE MEDICAL CENTER SANDRA & MALCOLM BERMAN CANCER INSTITUTE CANCER REGISTRY REPORT The Cancer Data Management System/Cancer Registry collects data on all types of cancer diagnosed or treated

More information